Clinical Trials Search Results
The results of your search are listed below. To view the details of a trial or study, click on the link. Or start a new search.
| Searched for: Wilms' Tumor | 6 results total |
A Phase I study of VEGF Trap (NSC #72477 ? IND #100137) in Children with Relapsed/Refractory Solid Tumors
Julie Park, MD
COG ADVL0714
A Phase I study of the Raf kinase and receptor tyrosine kinase inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in children with refractory solid tumors or refractory leukemias
Julie Park, MD
COG ADVL0413
A Phase I Study of Temozolomide, oral Irinotecan and Vincristine for Children with Refractory Solid Tumors
Julie Park, MD
COG ADVL0414
Treatment of High Risk Renal Tumors; A Groupwide Phase II Study.
Douglas Hawkins, MD
COG AREN0321
Treatment for Very Low, Low, and Standard Risk Favorable Histology Wilms Tumor. A Groupwide Phase III Study
Douglas Hawkins, MD
COG AREN0532
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Douglas Hawkins, MD
COG AREN0533
Search Options
OR
OR
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
- Talk to your health care providers first before making decisions about your health care.
- Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.
Terms of Use and Privacy Policy
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.
